The UNC Stroke Center is currently recruiting for several clinical trials and studies. These include trials of acute stroke treatments as well as trials studying stroke prevention.  Please call Anne Beckwith at (919) 843-8797 for more information.

The following are ongoing stroke clinical trials and studies:

ACUTE STROKE TREATMENT TRIALS (0-24h):

1. ALIAS-2: Albumin in acute ischemic stroke
2. IMS-3: Interventional management of stroke-3
3. POINT: Clopidogrel (Plavix®)and aspirin combination in TIA or minor ischemic stroke
4. HI-DEF: High dose Deferoxamine Mesylate in intracerebral hemorrhage

24-72 HOURS:

1. ASUBIO: Observational study to evaluate the Simplified-Stroke Rehabilitation Assessment of Movement  (S-STREAM) in ischemic stroke
2. PF-03049423: A Pfizer initiated study to measure the safety and efficacy of PF-03049423 in ischemic stroke

TRAUMATIC BRAIN INJURY:

1. ALERT: Evaluation of Biomarkers of Traumatic Brain Injury

INVESTIGATOR-INITIATED STROKE RESEARCH STUDIES:

1. Comparing clinical outcomes of ischemic stroke patients who undergo intervention with SOLITAIRE™ or standard evidence based management.
2. Inflammation in intracerebral hemorrhage imaging study

Click on the links above to find out more information regarding specific studies including inclusion/exclusion criteria

This website is to help patients, physicians and students in finding more information regarding Stroke and Stroke Care. The data provided on this website is only for informational use and is not an alternative to medical examination nor is this site intended to provide medical advice. If you are in search of medical advice, we strongly suggest you contact your physician to develop a personalized care plan.